The Biotech industry is up 1.6% in the last week, with Vitrolife up 22%. In the last 12 months, the industry was up 22%. Earnings are forecast to grow by 43% annually.
Has the Swedish Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sun, 21 Jul 2024 | SEK 204.8b | SEK 31.3b | -SEK 5,446,317,859.85 | 44.7x | -37.6x | 6.5x |
Tue, 18 Jun 2024 | SEK 190.0b | SEK 30.6b | -SEK 5,515,176,071.08 | 37.8x | -34.5x | 6.2x |
Thu, 16 May 2024 | SEK 196.0b | SEK 31.0b | -SEK 5,211,861,229.87 | 45.7x | -37.6x | 6.3x |
Sat, 13 Apr 2024 | SEK 179.8b | SEK 29.8b | -SEK 5,280,103,573.23 | 64.9x | -34.1x | 6x |
Mon, 11 Mar 2024 | SEK 191.0b | SEK 29.8b | -SEK 5,646,599,210.35 | 57.9x | -33.8x | 6.4x |
Wed, 07 Feb 2024 | SEK 186.2b | SEK 28.8b | -SEK 5,298,721,422.63 | 63.9x | -35.1x | 6.5x |
Fri, 05 Jan 2024 | SEK 184.0b | SEK 28.7b | -SEK 1,197,745,187.00 | 61.4x | -153.6x | 6.4x |
Sun, 03 Dec 2023 | SEK 172.5b | SEK 28.7b | -SEK 1,200,476,458.00 | 57.5x | -143.7x | 6x |
Tue, 31 Oct 2023 | SEK 156.6b | SEK 28.8b | -SEK 2,066,402,089.00 | 45.1x | -75.8x | 5.4x |
Thu, 28 Sep 2023 | SEK 158.6b | SEK 27.4b | -SEK 2,017,185,031.00 | 49.7x | -78.6x | 5.8x |
Sat, 26 Aug 2023 | SEK 157.3b | SEK 27.6b | -SEK 1,544,638,274.00 | 51.3x | -101.8x | 5.7x |
Mon, 24 Jul 2023 | SEK 157.6b | SEK 27.5b | -SEK 1,533,673,744.00 | 58.6x | -102.8x | 5.7x |
Wed, 21 Jun 2023 | SEK 167.1b | SEK 26.4b | -SEK 1,295,207,256.00 | 45.3x | -129.1x | 6.3x |
Fri, 19 May 2023 | SEK 171.9b | SEK 26.3b | -SEK 1,379,370,325.00 | 45x | -124.6x | 6.5x |
Sun, 16 Apr 2023 | SEK 175.9b | SEK 25.4b | -SEK 2,031,220,245.00 | 40.4x | -86.6x | 6.9x |
Tue, 14 Mar 2023 | SEK 166.3b | SEK 25.4b | -SEK 2,020,529,182.00 | 38x | -82.3x | 6.5x |
Thu, 09 Feb 2023 | SEK 177.6b | SEK 24.2b | -SEK 1,753,177,701.00 | 29.1x | -101.3x | 7.3x |
Sat, 07 Jan 2023 | SEK 157.9b | SEK 23.8b | -SEK 1,843,261,584.00 | 31.9x | -85.7x | 6.6x |
Mon, 05 Dec 2022 | SEK 163.0b | SEK 23.8b | -SEK 1,783,317,061.00 | 32.2x | -91.4x | 6.8x |
Wed, 02 Nov 2022 | SEK 150.3b | SEK 23.9b | -SEK 3,207,318,105.00 | 32.7x | -46.9x | 6.3x |
Fri, 30 Sep 2022 | SEK 154.6b | SEK 22.9b | -SEK 3,319,812,331.00 | 30.5x | -46.6x | 6.8x |
Sun, 28 Aug 2022 | SEK 161.7b | SEK 22.9b | -SEK 3,355,586,604.00 | 34.9x | -48.2x | 7.1x |
Tue, 26 Jul 2022 | SEK 167.7b | SEK 22.7b | -SEK 3,478,626,887.00 | 35.5x | -48.2x | 7.4x |
Thu, 23 Jun 2022 | SEK 146.7b | SEK 21.4b | -SEK 3,519,685,528.00 | 32.4x | -41.7x | 6.8x |
Sat, 21 May 2022 | SEK 154.2b | SEK 21.4b | -SEK 3,350,837,895.00 | 44.6x | -46x | 7.2x |
Mon, 18 Apr 2022 | SEK 176.2b | SEK 19.7b | -SEK 3,200,759,994.00 | 52.8x | -55.1x | 9x |
Wed, 16 Mar 2022 | SEK 156.9b | SEK 19.6b | -SEK 3,013,909,572.00 | 50.3x | -52x | 8x |
Fri, 11 Feb 2022 | SEK 173.8b | SEK 19.1b | -SEK 2,338,078,099.00 | 50.9x | -74.3x | 9.1x |
Sun, 09 Jan 2022 | SEK 186.0b | SEK 19.1b | -SEK 2,003,694,869.00 | 55.7x | -92.8x | 9.7x |
Tue, 07 Dec 2021 | SEK 173.6b | SEK 19.0b | -SEK 1,986,571,765.00 | 53x | -87.4x | 9.1x |
Thu, 04 Nov 2021 | SEK 200.4b | SEK 19.0b | -SEK 1,182,008,492.00 | 54.8x | -169.6x | 10.6x |
Sat, 02 Oct 2021 | SEK 202.5b | SEK 18.1b | -SEK 1,339,324,385.00 | 42.7x | -151.2x | 11.2x |
Mon, 30 Aug 2021 | SEK 204.6b | SEK 18.1b | -SEK 1,175,418,285.95 | 59.5x | -174.1x | 11.3x |
-163.8x
Which industries have driven the changes within the Swedish Healthcare industry?
SE Market | -1.84% | |
Healthcare | 0.80% | |
Biotech | 1.60% | |
Biotech | 1.60% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
VITR Vitrolife | SEK 221.20 | 22.2% +SEK 5.4b | 31.7% | PS8.5x | |
BONEX Bonesupport Holding | SEK 289.80 | 2.4% +SEK 446.9m | 104.5% | PE66x | |
BINV BioInvent International | SEK 43.35 | 18.4% +SEK 444.2m | 150.6% | PS46.6x | |
EGTX Egetis Therapeutics | SEK 6.16 | 13.7% +SEK 216.5m | 54.6% | PS28.7x | |
PROB Probi | SEK 281.00 | 4.1% +SEK 125.3m | 50.3% | PE233.7x |